0000950170-24-088659.txt : 20240731
0000950170-24-088659.hdr.sgml : 20240731
20240731164543
ACCESSION NUMBER: 0000950170-24-088659
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240731
DATE AS OF CHANGE: 20240731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shook David
CENTRAL INDEX KEY: 0001959742
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 241162664
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1150 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (925) 407-1049
MAIL ADDRESS:
STREET 1: 1150 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
ownership.xml
4
X0508
4
2024-07-15
0001787400
Nkarta, Inc.
NKTX
0001959742
Shook David
C/O NKARTA, INC.
1150 VETERANS BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
See Remarks
false
Common Stock
2024-07-15
4
A
false
23421
0
A
139945
D
Stock Option (right to buy)
7.02
2024-07-15
4
A
false
30000
0
A
2034-07-14
Common Stock
30000
30000
D
This transaction is inadvertently filed late due to an administrative error.
Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on August 20, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 15, 2024.
Chief Medical Officer, Head of Research & Development
/s/ Alicia Hager, as Attorney-in-Fact
2024-07-31